{"id":57781,"date":"2023-07-21T10:05:05","date_gmt":"2023-07-21T08:05:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/"},"modified":"2023-07-21T10:05:05","modified_gmt":"2023-07-21T08:05:05","slug":"portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/","title":{"rendered":"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation"},"content":{"rendered":"
\n

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News:<\/p>\n

<\/a>
<\/a><\/p>\n

\nMedian Technologies (Euronext Growth – ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering brokerage for Individual and institutional investors, and financial operations for corporate and Institutional clients.<\/p>\n

\nIn the initiation report published on July 20, 2023, Portzamparc Groupe BNP Paribas initiates the coverage of the stock with a Strong Buy recommendation.<\/p>\n

\nAbout Portzamparc Groupe BNP Paribas:<\/strong> <\/b>Portzamparc’s offering is built around three areas of expertise: support for private and institutional investors on the stock market, with a transaction volume of nearly \u20ac9 billion; third-party asset management, with \u20ac4 billion in assets under management; and market operations for SMEs\/ETIs, with undisputed leadership in IPOs. From IPOs to financial analysis, Portzamparc’s experience and reputation make it the benchmark for mid-cap companies.<\/p>\n

\nAbout Median Technologies:<\/strong> <\/b>Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy\u00ae, our AI-powered imaging platform for the development of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.<\/p>\n

\nFounded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label \u201cInnovative company\u201d by the BPI and is listed on Euronext Growth market (Paris). FR0011049824\u2013 ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nMedian Technologies<\/b>
Emmanuelle Leygues
\n
Head of Corporate Marketing & Financial Communications
\n
+33 6 10 93 58 88
\n
emmanuelle.leygues@mediantechnologies.com<\/a><\/p>\n

\nPress – ALIZE RP<\/b>
Caroline Carmagnol
\n
+33 6 64 18 99 59
\n
median@alizerp.com<\/a><\/p>\n

\nInvestors – ACTIFIN<\/b>
Ghislaine Gasparetto
\n
+33 6 21 10 49 24
\n
ggasparetto@actifin.fr<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (Euronext Growth – ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering brokerage for Individual and institutional investors, and financial operations for corporate and Institutional clients. In the initiation report published on July 20, 2023, Portzamparc Groupe BNP … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57781","6":"format-standard","7":"category-industry"},"yoast_head":"\nPortzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (Euronext Growth – ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering brokerage for Individual and institutional investors, and financial operations for corporate and Institutional clients. In the initiation report published on July 20, 2023, Portzamparc Groupe BNP ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-21T08:05:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230720213843\/en\/1343975\/21\/Median_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation\",\"datePublished\":\"2023-07-21T08:05:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/\"},\"wordCount\":352,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230720213843\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/\",\"name\":\"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230720213843\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"datePublished\":\"2023-07-21T08:05:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230720213843\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230720213843\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/","og_locale":"en_US","og_type":"article","og_title":"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation - Pharma Trend","og_description":"SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (Euronext Growth – ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering brokerage for Individual and institutional investors, and financial operations for corporate and Institutional clients. In the initiation report published on July 20, 2023, Portzamparc Groupe BNP ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/","og_site_name":"Pharma Trend","article_published_time":"2023-07-21T08:05:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230720213843\/en\/1343975\/21\/Median_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation","datePublished":"2023-07-21T08:05:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/"},"wordCount":352,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230720213843\/en\/1343975\/21\/Median_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/","url":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/","name":"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230720213843\/en\/1343975\/21\/Median_RGB.jpg","datePublished":"2023-07-21T08:05:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230720213843\/en\/1343975\/21\/Median_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230720213843\/en\/1343975\/21\/Median_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/portzamparc-groupe-bnp-paribas-initiates-the-coverage-of-median-technologies-with-a-strong-buy-recommendation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a \u201cStrong Buy\u201d Recommendation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57781"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57781\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}